Back

Tumor Landscape Analysis: An Ecologically Informed Framework to Understand Tumor Microenvironments

Cisneros, L.; Toruner, M. D.; Fernandez-Zapico, M. E.; Maley, C. C.; Carr, R. M.

2025-04-22 cancer biology
10.1101/2025.04.22.646608 bioRxiv
Show abstract

Tumor microenvironments (TMEs) are spatially complex and dynamic systems shaped by evolutionary pressures, tissue architecture, and cellular interactions. To capture this complexity, we developed the Tumor Landscape Analysis (TLA) pipeline, a computational framework applying principles from landscape ecology and spatial statistics to quantitatively characterize tumor spatial heterogeneity. TLA integrates spatially resolved pathology data, including whole-cell, point-based, and region-level formats, and computes multiscale metrics to assess cell distributions, neighborhood relationships, and tissue-level organization. The framework leverages ecological indices such as the Morisita-Horn index, Ripleys H function, and Shannon diversity to quantify intercellular proximity, spatial clustering, and cellular diversity. It also uses the concept of local microenvironments (LMEs), data-driven ecological niches defined by local cell-type abundance and spatial uniformity, enabling unsupervised and reproducible classification of tumor regions. The use of fragmentation metrics, including patch density, shape complexity, and interspersion, provide further insight into spatial disorganization and emergent tissue architecture. TLA is agnostic to imaging modality and biological context, supporting broad applicability across tumor types and sample formats. By translating complex tissue architectures into interpretable spatial metrics, the pipeline enables integrative analyses that link spatial ecology to clinical and molecular phenotypes. This approach facilitates a deeper understanding of how spatial features contribute to tumor progression, therapeutic resistance, and clinical outcomes, offering new opportunities for precision oncology rooted in spatial systems biology.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Cancer Research
116 papers in training set
Top 0.1%
22.1%
2
npj Precision Oncology
48 papers in training set
Top 0.1%
9.9%
3
Nature Communications
4913 papers in training set
Top 30%
6.3%
4
PLOS Computational Biology
1633 papers in training set
Top 6%
6.3%
5
Genome Medicine
154 papers in training set
Top 1%
6.2%
50% of probability mass above
6
Clinical Cancer Research
58 papers in training set
Top 0.3%
4.2%
7
Scientific Reports
3102 papers in training set
Top 39%
3.5%
8
PLOS ONE
4510 papers in training set
Top 47%
2.3%
9
Cell Reports Medicine
140 papers in training set
Top 3%
2.1%
10
Cell Systems
167 papers in training set
Top 6%
1.9%
11
Cell Reports Methods
141 papers in training set
Top 2%
1.9%
12
Advanced Science
249 papers in training set
Top 10%
1.9%
13
npj Digital Medicine
97 papers in training set
Top 2%
1.9%
14
Cell Reports
1338 papers in training set
Top 25%
1.7%
15
npj Systems Biology and Applications
99 papers in training set
Top 1%
1.3%
16
Nature Cancer
35 papers in training set
Top 1%
1.2%
17
Breast Cancer Research
32 papers in training set
Top 0.4%
1.1%
18
Science Advances
1098 papers in training set
Top 24%
1.1%
19
Cancers
200 papers in training set
Top 4%
0.9%
20
Cancer Research Communications
46 papers in training set
Top 1.0%
0.8%
21
Modern Pathology
21 papers in training set
Top 0.4%
0.8%
22
Cancer Discovery
61 papers in training set
Top 2%
0.8%
23
Patterns
70 papers in training set
Top 2%
0.8%
24
Cancer Cell
38 papers in training set
Top 2%
0.7%
25
Briefings in Bioinformatics
326 papers in training set
Top 7%
0.7%
26
npj Breast Cancer
18 papers in training set
Top 0.2%
0.7%
27
Communications Biology
886 papers in training set
Top 25%
0.7%
28
Nature Biomedical Engineering
42 papers in training set
Top 2%
0.7%
29
Nature Biotechnology
147 papers in training set
Top 8%
0.7%
30
JCI Insight
241 papers in training set
Top 7%
0.7%